Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04701307
Brief Title: Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

First Submitted : January 6, 2021
First Submitted that Met QC Criteria : January 6, 2021
First Posted : January 8, 2021

Last Update Submitted that Met QC Criteria : September 30, 2021
Last Update Posted : October 6, 2021